8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	July 31, 2016
	Date of Report (Date of earliest event reported)
	NU SKIN ENTERPRISES, INC.
	(Exact name of registrant as specified in its charter)
Delaware		001-12421	87-0565309
(State or other jurisdiction of incorporation)		(Commission File Number)	(IRS Employer Identification Number)
	75 West Center Street Provo, Utah 84601
	(Address of principal executive offices and zip code)
	(801) 345-1000
	(Registrant's telephone number, including area code)
	N/A
	(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Item 2.02Results of Operations and Financial Condition.

On August 4, 2016, Nu Skin Enterprises, Inc. (the "Company") issued a press release announcing its financial results for the three- and six-month periods ended June 30, 2016, and certain other information.  A copy of the Company's press release is attached as Exhibit 99.1 to this report and incorporated by reference.

The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

The press release furnished herewith in Exhibit 99.1 may contain non-GAAP financial measures. Management believes non-GAAP financial measures assist management and investors in evaluating and comparing period-to-period results and projections in a more meaningful and consistent manner.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)

On July 31, 2016, the Board of Directors of Nu Skin Enterprises, Inc. (the "Company") appointed Zheqing (Simon) Shen as a director of the Company, increasing the size of the Board of Directors from eight to nine members.

Mr. Shen was appointed to the Company's Board of Directors pursuant to the Investment Agreement that the Company entered into on June 14, 2016 with Ping An ZQ China Growth Opportunity Limited ("Ping An ZQ"), a company owned by a consortium of investors led by Ping An of China Securities (Hong Kong) Company Ltd. and ZQ Capital Limited, relating to the issuance to Ping An ZQ of $210 million principal amount of convertible 4.75% senior notes due 2020. Interest on the convertible notes is payable semiannually on June 15 and December 15 of each year, beginning on December 15, 2016. Mr. Shen is a partner at ZQ Capital Limited and a director at Ping An ZQ.

Mr. Shen will be compensated for his services as a director of the Company in accordance with the Company's non-employee director compensation program as described in the Company's 2016 Proxy Statement, as well as the indemnification arrangements that the Company has with its directors and executive officers.

The Board of Directors has not yet determined the committee(s), if any, on which Mr. Shen will serve.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibit.

99.1 Nu Skin Enterprises' press release dated August 4, 2016, regarding financial results for the three- and six-month periods ended June 30, 2016.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NU SKIN ENTERPRISES, INC. (Registrant)

/s/ Ritch Wood

Ritch Wood Chief Financial Officer

Date:  August 4, 2016

EXHIBIT INDEX

Exhibit No.Exhibit Description

99.1 Nu Skin Enterprises' press release dated August 4, 2016, regarding financial results for the three- and six-month periods ended June 30, 2016.

EX-99.1

FOR IMMEDIATE RELEASE

CONTACTS:

Investors — Scott Pond (801) 345-2657, spond@nuskin.com Media — Kara Schneck (801) 345-2116, kschneck@nuskin.com

NU SKIN ENTERPRISES REPORTS SECOND-QUARTER 2016 RESULTS

Company Raises Annual Guidance

PROVO, Utah — Aug. 4, 2016 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter results with revenue above guidance at $600.5 million, compared to $560.2 million in the prior-year period. Quarterly revenue improved 7 percent, or 10 percent on a constant-currency basis. Earnings per share for the quarter were $0.79 compared to $0.75 in the prior-year period. Earnings were negatively impacted $0.13 per share due to foreign currency translation charges recorded in other income/expense.

"We are pleased with our second-quarter results and remain optimistic about the future as we continue to introduce our latest ageLOC products," said Truman Hunt, president and chief executive officer. "During the quarter, we held significant product introduction events in South Asia/Pacific and Greater China, generating revenue growth of 36 and 18 percent, respectively. We are also encouraged with the increase in sales leaders during the quarter, a reflection of the strength of our product launches."

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 2

Regional Results

The company's regional revenue results for the three-month periods ended June 30 are presented in the following table.

	2016		2015		% Change		Constant Currency % Change
Greater China	$	236,716	$	200,136		18%		24%
North Asia		165,885		172,943		(4%)		(6%)
Americas		67,884		83,468		(19%)		(15%)
South Asia/Pacific		92,297		68,023		36%		42%
EMEA		37,693		35,639		6%		5%
Total	$	600,475	$	560,209		7%		10%

The company's regional revenue results for the six-month periods ended June 30 are presented in the following table.

	2016		2015		% Change		Constant Currency % Change
Greater China	$	395,427	$	387,503		2%		7%
North Asia		317,094		345,009		(8%)		(7%)
Americas		133,632		163,340		(18%)		(13%)
South Asia/Pacific		155,875		138,840		12%		19%
EMEA		70,278		68,849		2%		3%
Total	$	1,072,306	$	1,103,541		(3%)		1%

The Company's regional actives and sales leaders statistics are presented in the following table.

	As of June 30, 2016				As of June 30, 2015				% Increase (Decrease)
	Actives		Sales Leaders		Actives		Sales Leaders		Actives		Sales Leaders
Greater China		257,000		31,554		215,000		25,956		19.5%		21.6%
North Asia		356,000		16,128		387,000		16,991		(8.0%)		(5.1%)
Americas		165,000		6,515		180,000		7,892		(8.3%)		(17.4%)
South Asia/Pacific		113,000		7,747		120,000		7,279		(5.8%)		6.4%
EMEA		121,000		4,168		113,000		4,042		7.1%		3.1%
Total		1,012,000		66,112		1,015,000		62,160		(0.3%)		6.4%

"Actives" are persons who purchased products directly from the company during the previous three months.

"Sales Leaders" are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 3

Operational Performance

The company's operating margin improved to 13.3 percent, compared to 12.8 percent in the prior-year period. Gross margin for the quarter was 78.7 percent, compared to 80.3 percent in the prior-year quarter. Both gross and operating margins continued to be negatively impacted by foreign currency fluctuations. Selling expenses, as a percent of revenue, were 41.4 percent, compared to 42.7 percent in the second quarter of 2015. General and administrative expenses, as a percent of revenue, were 24.0 percent, compared to 24.8 percent in the prior-year period. The company's effective income tax rate for the quarter was 35.0 percent, compared to 35.3 percent in the second quarter of last year. Dividend payments during the quarter were $19.9 million, and the company repurchased $4.3 million of its outstanding shares, with $422.7 million remaining in the authorized share repurchase plan at the end of the quarter.

Outlook

"We are pleased with the solid results of our product launches and growth of our sales force in the second quarter, which we believe will positively impact our business going forward," said Hunt. "In July, we executed a highly successful introduction of ageLOC Youth in South Korea, and we look forward to new product initiatives in all of our regions throughout the remainder of the year.

"Our balance sheet continues to be strong, boosted by positive cash flow from operations for the quarter of $139 million, with continued improvements to our inventory balance. Our cash balance includes approximately $200 million of proceeds from the recent investment by Ping An Securities during the second quarter, which we plan to deploy in repurchasing shares over the balance of the year," concluded Hunt.

"We are pleased with our results this quarter and are raising our revenue guidance for the year to $2.20 to $2.24 billion, assuming a negative foreign currency impact of 2 to 3 percent," said Ritch Wood, chief financial officer. "For the third quarter, we project revenue of $560 to $580 million including a negative currency impact of 1 to 2 percent. We project third-quarter earnings per share of $0.80 to $0.84, and full-year earnings per share of $2.44 to $2.54, or $2.80 to $2.90 when excluding a $0.36 per share non-cash Japan customs charge taken in the first quarter."

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 4

The Nu Skin management team will host a conference call with the investment community on Aug. 4 at 5 p.m. (EDT). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available at the same URL through Aug. 19, 2016.

About Nu Skin Enterprises, Inc.

Founded more than 30 years ago, Nu Skin Enterprises, Inc. develops and distributes innovative consumer products, offering a comprehensive line of premium-quality beauty and wellness solutions in more than 50 markets worldwide. The company builds upon its scientific expertise in both skin care and nutrition to continually develop innovative product brands that include the Nu Skin® personal care brand, the Pharmanex® nutrition brand, and most recently, the ageLOC® anti-aging brand. Since its introduction in 2008, the ageLOC brand has generated more than $5 billion in sales, and built a loyal following for such products as the ageLOC Youth nutritional supplement, the ageLOC Me® customized skin care system, as well as the ageLOC TR90® weight management and body shaping system. Nu Skin sells its products through a global network of sales leaders. As a long-standing member of direct selling associations globally, Nu Skin is committed to the industry's consumer guidelines that protect and support those who sell and purchase its products through the direct selling channel. Nu Skin is also traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskin.com.

Please Note: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, growth, initiatives and new product introductions; projections regarding revenue, earnings per share, foreign currency fluctuations, and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

· any failure of current or planned initiatives or products to generate interest among our sales force and customers and generate sponsoring and selling activities on a sustained basis;

· risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 5

· risk that direct selling laws and regulations in any of our markets, including the United States and China, may be modified, interpreted or enforced in a manner that results in negative changes to our business model or negatively impacts our revenue, sales force or business, including through the interruption of sales activities, loss of licenses, imposition of fines, or any other adverse actions or events;

· risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, and increased risk of inventory write-offs if we over-forecast demand for a product or change our planned initiatives or launch strategies;

· regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;

· adverse publicity related to the company's business, products, industry or any legal actions or complaints by the company's sales force or others;

· risk that litigation, investigations or other legal matters could result in settlements, assessments or damages that significantly affect financial results;

· unpredictable economic conditions and events globally;

· any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and

· continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 6

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Second Quarters Ended June 30, 2016 and 2015
(in thousands, except per share amounts)
	2016			2015
Revenue	$	600,475		$	560,209
Cost of sales		128,205			110,263
Gross profit		472,270			449,946
Operating expenses:
Selling expenses		248,363			239,449
General and administrative expenses		144,109			138,696
Total operating expenses		392,472			378,145
Operating income		79,798			71,801
Other income (expense), net		(11,060	)		(2,758	)
Income before provision for income taxes		68,738			69,043
Provision for income taxes		24,025			24,386
Net income	$	44,713		$	44,657
Net income per share:
Basic	$	0.80		$	0.76
Diluted	$	0.79		$	0.75
Weighted average common shares outstanding:
Basic		55,952			58,506
Diluted		56,356			59,713

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 7

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Six-Month Periods Ended June 30, 2016 and 2015
(in thousands, except per share amounts)
	2016			2015
Revenue	$	1,072,306		$	1,103,541
Cost of sales		266,074			215,318
Gross profit		806,232			888,223
Operating expenses:
Selling expenses		443,922			473,454
General and administrative expenses		274,363			274,322
Total operating expenses		718,285			747,776
Operating income		87,947			140,447
Other income (expense), net		(13,923	)		(15,026	)
Income before provision for income taxes		74,024			125,421
Provision for income taxes		25,995			44,482
Net income	$	48,029		$	80,939
Net income per share:
Basic	$	0.86		$	1.38
Diluted	$	0.85		$	1.35
Weighted average common shares outstanding:
Basic		55,953			58,747
Diluted		56,388			59,994

-more-

Nu Skin Enterprises, Inc.

Aug. 4, 2016

Page 8

NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(in thousands)
	June 30, 2016			December 31, 2015
ASSETS
Current assets:
Cash and cash equivalents	$	544,848		$	289,354
Current investments		11,503			14,371
Accounts receivable		31,706			35,464
Inventories, net		259,933			265,256
Prepaid expenses and other		162,710			101,947
		1,010,700			706,392
Property and equipment, net		453,342			454,537
Goodwill		114,954			112,446
Other intangible assets, net		67,410			67,009
Other assets		134,463			165,459
Total assets	$	1,780,869		$	1,505,843
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	43,360		$	28,832
Accrued expenses		350,849			310,916
Current portion of long-term debt		96,896			67,849
		491,105			407,597
Long-term debt		362,051			181,745
Other liabilities		97,473			90,880
Total liabilities		950,629			680,222
Stockholders' equity:
Class A common stock		91			91
Additional paid-in capital		431,459			419,921
Treasury stock, at cost		(1,032,117	)		(1,017,063	)
Accumulated other comprehensive loss		(71,463	)		(71,269	)
Retained earnings		1,502,270			1,493,941
		830,240			825,621
Total liabilities and stockholders' equity	$	1,780,869		$	1,505,843

###